FDA recall D-1164-2016
Cantrell Drug Company · Class II · drug
Product
MIDAZOLAM HCl in 0.9% Sodium Chloride Injection, 2 mg/2 mL (1 mg/mL), in 2 mL syringe, Rx only, Cantrell Drug Co., Little Rock, AR --- NDC 52533-001-16 UPC: 0100352533001161
Reason for recall
Subpotent Drug
Distribution
Nationwide
Key facts
- Status
- Terminated
- Initiation date
- 2015-08-21
- Report date
- 2016-07-13
- Termination date
- 2017-02-03
- Voluntary/Mandated
- Voluntary: Firm initiated
- Location
- Little Rock, AR, United States
Primary source
https://www.accessdata.fda.gov/scripts/ires/index.cfm?Product=D-1164-2016